Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in Lichen Planopilaris is caused by immune system issues damaging hair follicles and stem cells.

Alopecia areata is a reversible, autoimmune-related hair loss that can have significant emotional impact and uncertain treatment effectiveness.

The textbook "Dermatology" is highly recommended for its comprehensive content, user-friendly design, and extensive visual aids.

Hair loss can be treated with medications like minoxidil and finasteride or surgery, but treatment effectiveness varies by alopecia type and accurate diagnosis is important.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Current treatments for alopecia show no significant long-term benefits.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Fractional lasers seem effective and safe for treating hair loss, but more research is needed to find the best treatment methods.

Early treatment of fibrosing alopecia in a pattern distribution may improve outcomes.

CCCA is a scarring hair disorder mainly affecting people of African descent, needing better awareness and treatment.

Autoimmune diseases cause the immune system to attack the body, and management varies as some are curable and others are not.

Autoimmune diseases cause the immune system to attack the body, and management varies as some are curable and others are not.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

Activating TLR5 in the gut can extend lifespan and improve health in aged mice.

Mice without the vitamin D receptor have bone issues and other health problems, suggesting vitamin D is important for preventing various diseases in humans.

The secretions of mesenchymal stem cells could be used for healing without using the cells themselves.

Photobiomodulation therapy using red and near-infrared light can reduce inflammation and aid in healing various conditions.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

The skin has a complex immune system that is essential for protection and healing, requiring more research for better wound treatment.

The document concludes that the understanding of scar formation is incomplete and current prevention and treatment for hypertrophic scars and keloids are not fully effective.

Polysaccharides have many health benefits and are used in drugs, but isolating and purifying them is complex and requires careful methods.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

Niosomes are a promising, stable, and cost-effective drug delivery system with potential for improved targeting and safety.

Melatonin is important for skin health and protection, and can be made by the skin or applied to it.

Biomaterials with MSC-derived substances could improve tissue repair and have advantages over direct cell therapy.

Chemotherapy causes hair loss by damaging hair follicles and stem cells, with more research needed for prevention and treatment.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

Stress stops hair growth in mice by causing early hair growth phase end and harmful inflammation through a specific nerve-related pathway.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.